文献速递神经免疫

鞘内IgG合成与多发性硬化残疾恶化的关联

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
PubMed 文献 · JAMA Neurol · 2019-01-01

鞘内IgG合成可能是残疾恶化的有用标志物,有助于早期治疗决策。

要点

  • 鞘内IgG合成与4年EDSS恶化风险独立相关(OR 2.02)。
  • 有鞘内IgG合成者4年恶化率28.4%,无者18.1%。
  • 其他常规脑脊液参数与EDSS恶化无关联。

核心结论

  • 新诊断的复发缓解型MS或临床孤立综合征患者若存在鞘内IgG合成,4年内EDSS恶化的风险更高且时间更短。
  • 鞘内IgG合成可能是残疾恶化的有用标志物,有助于早期治疗决策。

研究设计与样本

  • 共纳入673例患者,其中女性459例(68.2%),基线平均(SD)年龄34(10)岁。

主要发现

  • 鞘内IgG合成与更早的EDSS恶化相关:4年时,有和无鞘内IgG合成者的恶化率分别为28.4%(95%CI 22.7%-34.1%)和18.1%(95%CI 12.4%-23.9%)。
  • 其他常规脑脊液参数与EDSS恶化无关联。

临床怎么用

  • 对于新诊断的复发缓解型MS或临床孤立综合征患者,检测鞘内IgG合成可能有助于识别残疾恶化高风险者。
  • 鞘内IgG合成结果或可辅助早期治疗决策。

局限性

  • 数据收集开始于假设形成之前。
  • 1376例患者中703例因缺失脑脊液或EDSS数据被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Reliable biomarkers associated with disability worsening in multiple sclerosis (MS) are still needed. OBJECTIVE: To determine a possible association of intrathecal IgG synthesis and early disability worsening as measured by Expanded Disability Status Scale (EDSS) scoring in patients with relapsing-remitting MS or clinically isolated syndrome. DESIGN, SETTING, AND PARTICIPANTS: Cerebrospinal fluid measurements and clinical data from the observational longitudinal German national multiple sclerosis cohort were analyzed. Patients were recruited between August 2010 and November 2015 from 18 centers. Data analysis was completed from August 2018 to December 2018. EXPOSURE: Patients were offered standard immunotherapies per national treatment guidelines. MAIN OUTCOMES AND MEASURES: A possible association between intrathecal IgG synthesis and risk of EDSS worsening 4 years after study inclusion was tested as the primary end point by multivariable binomial regression analysis. Kaplan-Meier analysis with a log-rank test was used to assess the association of intrathecal IgG synthesis with the time to EDSS worsening. Associations between intrathecal IgM or IgA synthesis and other cerebrospinal fluid parameters and EDSS worsening were analyzed as exploratory end points. Data collection began before the hypotheses were formulated. RESULTS: Of all 1376 patients in the German Competence Network of Multiple Sclerosis cohort, 703 patients were excluded owing to missing cerebrospinal fluid or EDSS data. Of the 673 included patients, 459 (68.2%) were women. The mean (SD) age at baseline was 34 (10) years. Intrathecal IgG synthesis was associated with a higher risk of EDSS worsening after 4 years (odds ratio, 2.02 [95% CI, 1.15-3.58]; P = .01), independent of the occurrence of relapses and disease-modifying therapy. Additionally, intrathecal IgG synthesis was associated with earlier EDSS worsening; 4 years after study entry, worsening occurred in 28.4% (95% CI, 22.7%-34.1%) and 18.1% (95% CI, 12.4%-23.9%) of patients with and without intrathecal IgG synthesis, respectively. No association of other routine cerebrospinal fluid parameters with EDSS worsening was found. CONCLUSIONS AND RELEVANCE: Patients with new diagnoses of relapsing-remitting multiple sclerosis or clinically isolated syndrome with intrathecal IgG synthesis had a higher risk of and shorter time to EDSS worsening across a 4-year period of follow-up. Intrathecal IgG synthesis is a potentially useful marker for disability worsening in patients with multiple sclerosis and may be useful for early treatment decisions.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Gasperi C, Salmen A, Antony G, et al. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. JAMA Neurol. 2019. PMID: 31034002. doi:10.1001/jamaneurol.2019.0905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。